White Papers

  1. Five Preventable Clinical Design Pitfalls And How To Avoid Them 7/21/2026

    While late-stage trial attrition is often attributed to inadequate safety or efficacy, the true failure may be insufficient upstream planning and/or misalignment between clinical and commercial goals.

  2. Strategic Implications Of The Single Phase 3 Approval Paradigm 7/21/2026

    As FDA single-trial approvals gain traction, CNS developers need stronger early evidence. Learn how biomarkers, patient selection, and regulatory strategy can accelerate development.

  3. Busy Quarter For Gene, Cell, RNA Therapies 7/21/2026

    Explore how Q2 brought renewed momentum for gene, cell, and RNA therapies and grew confidence in the future of advanced medicine with rising approvals, expanding pipelines, and increased investment.

  4. Rapid Expansion Of Peptide And Nanobody Drug Conjugates 7/21/2026

    Peptide and nanobody drug conjugates are gaining momentum, with 106 active programs identified globally. Learn more about the fast-evolving space for targeted drug delivery and competitive opportunities.

  5. Monitoring Atrial Fibrillation In Clinical Research: The Case For Continuous Wearable Assessment 7/9/2026

    Learn how continuous wearable monitoring can uncover AFib that standard ECGs miss and strengthen trial-grade endpoints.

  6. Capital Efficiency In Cardiovascular Outcomes Trials 7/8/2026

    New modeling shows aligning clinical and manufacturing operations in heart trials can cut costs, speed timelines, and boost expected program value.

  7. Navigating Complexity In Master Protocols With Key Operational Partners 7/5/2026

    Complex adaptive trials offer real efficiency gains, but success hinges on having experienced partners to manage the operational details.

  8. Five Ways Centralized Trial Finance Improves Site And Patient Satisfaction 6/15/2026

    Centralizing payments and logistics improves transparency, accelerates reimbursements, and supports better site performance and patient retention in clinical trials.

  9. 2026 Clinical Trials: Strong Headwinds, Winds Of Change 6/11/2026

    Are your Phase I–III/IV clinical studies prepared for today's regulatory landscape? Learn how leading organizations are addressing compliance, transparency, and data ownership risks.

  10. How Remote Pharmacy Monitoring Improves Trial Compliance 6/10/2026

    Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.